Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Doxycycline, meningo vax reduce STI incidence among MSM on PrEP
Use of doxycycline as postexposure prophylaxis (PEP) results in a significant decrease in the incidence of Chlamydia trachomatis (CT) and syphilis and demonstrates a significant impact on the incidence of Neisseria gonorrhoeae (GC), reports a study presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI). Meningococcal B vaccine also helps lower the incidence of GC.
Doxycycline, meningo vax reduce STI incidence among MSM on PrEP
28 Feb 2023ARAMIS boosts DAPT potential for mild stroke
In the ARAMIS* trial, dual antiplatelet therapy (DAPT) using clopidogrel and aspirin was noninferior to intravenous thrombolysis (IVT) using alteplase in Chinese patients with minor nondisabling ischaemic stroke presenting within 4.5 hours of symptom onset.
ARAMIS boosts DAPT potential for mild stroke
28 Feb 2023PrEP use tied to ‘stable’ STI incidence, sexual behaviour among MSM
The incidence of sexually transmitted infection (STI) over the first 4 years of pre-exposure prophylaxis (PrEP) use remains high and stable, but the incidence of chlamydia and gonorrhea has slightly decreased among daily PrEP users, as shown in a study presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI).
PrEP use tied to ‘stable’ STI incidence, sexual behaviour among MSM
27 Feb 2023Tirofiban improves functional outcome, prevents haemorrhage in stroke patients
Endovascular treatment (EVT) with intravenous tirofiban prior to thrombectomy appears to improve functional outcome and reduce the risk of any intracranial haemorrhage in patients with large vessel occlusion treated within 4.5 hours after stroke onset compared with alteplase, a study has shown.
Tirofiban improves functional outcome, prevents haemorrhage in stroke patients
26 Feb 2023Zinc supplements may improve survival in nonmetastatic prostate cancer
Postdiagnostic use of low-dose zinc supplement may help reduce the risk of lethal prostate cancer and all-cause mortality among patients with nonmetastatic prostate cancer, suggests a recent study.
Zinc supplements may improve survival in nonmetastatic prostate cancer
26 Feb 2023Omega-3 supplementation may protect against premature death in diabetes population
Increased intake of omega-3 fatty acids is associated with lower all-cause mortality in individuals with diabetes, as reported in a study.
Omega-3 supplementation may protect against premature death in diabetes population
25 Feb 2023SRT plus GnRH agonist with acetate/prednisone, apalutamide improves prostate cancer survival
Postoperative salvage radiotherapy (SRT) plus 6 months of androgen deprivation therapy (ADT) with abiraterone acetate/prednisone (AAP) and apalutamide (Apa) results in better progression-free (PFS) and metastasis-free survival (MFS) among patients with prostate cancer, findings from FORMULA-509 have shown. However, the primary analysis did not reach the prespecified threshold for statistical significance.